123 related articles for article (PubMed ID: 38440830)
1.
Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L574-L588. PubMed ID: 38440830
[TBL] [Abstract][Full Text] [Related]
2.
Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
bioRxiv; 2024 Feb; ():. PubMed ID: 38352468
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles secreted by primary human bronchial epithelial cells reduce
Sarkar S; Barnaby R; Nymon AB; Taatjes DJ; Kelley TJ; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L164-L174. PubMed ID: 38084406
[TBL] [Abstract][Full Text] [Related]
4. Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles.
Koeppen K; Barnaby R; Jackson AA; Gerber SA; Hogan DA; Stanton BA
PLoS One; 2019; 14(1):e0211290. PubMed ID: 30682135
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
[No Abstract] [Full Text] [Related]
6. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa.
Park KS; Lee J; Jang SC; Kim SR; Jang MH; Lötvall J; Kim YK; Gho YS
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):637-45. PubMed ID: 23713467
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.
Martin C; Ohayon D; Alkan M; Mocek J; Pederzoli-Ribeil M; Candalh C; Thevenot G; Millet A; Tamassia N; Cassatella MA; Thieblemont N; Burgel PR; Witko-Sarsat V
Am J Respir Cell Mol Biol; 2016 May; 54(5):740-50. PubMed ID: 26517580
[TBL] [Abstract][Full Text] [Related]
9. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
Esoda CN; Kuehn MJ
mBio; 2019 Nov; 10(6):. PubMed ID: 31744920
[No Abstract] [Full Text] [Related]
11. Anesthetics isoflurane and sevoflurane attenuate flagellin-mediated inflammation in the lung.
Yuki K; Mitsui Y; Shibamura-Fujiogi M; Hou L; Odegard KC; Soriano SG; Priebe GP; Koutsogiannaki S
Biochem Biophys Res Commun; 2021 Jun; 557():254-260. PubMed ID: 33894411
[TBL] [Abstract][Full Text] [Related]
12.
Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrins reduce the ability of Pseudomonas aeruginosa outer-membrane vesicles to reduce CFTR Cl
Barnaby R; Koeppen K; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L206-L215. PubMed ID: 30358440
[TBL] [Abstract][Full Text] [Related]
14. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
Wang Y; Cela E; Gagnon S; Sweezey NB
Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
[TBL] [Abstract][Full Text] [Related]
15. Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
Vazquez-Espinosa E; Marcos C; Alonso T; Giron RM; Gomez-Punter RM; Garcia-Castillo E; Zamora E; Cisneros C; Garcia J; Valenzuela C; Ancochea J
Expert Rev Anti Infect Ther; 2016; 14(1):9-17. PubMed ID: 26559549
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells.
Tsuchiya M; Kumar P; Bhattacharyya S; Chattoraj S; Srivastava M; Pollard HB; Biswas R
J Interferon Cytokine Res; 2013 Mar; 33(3):121-9. PubMed ID: 23289731
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
[TBL] [Abstract][Full Text] [Related]
20. Vx-809/Vx-770 treatment reduces inflammatory response to Pseudomonas aeruginosa in primary differentiated cystic fibrosis bronchial epithelial cells.
Ruffin M; Roussel L; Maillé É; Rousseau S; Brochiero E
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L635-L641. PubMed ID: 29351441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
